The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Congressionally Directed Medical Research Programs -- Peer Reviewed Cancer Research Program -- Horizon Award
The FY19 PRCRP Horizon Award supports junior-level scientists in conducting impactful research with the mentorship of an experienced cancer researcher (i.e., Mentor). The intent of the Horizon Award is to recruit junior-level scientists to perform research in one of the FY19 PRCRP Topic Areas. The Horizon Award challenges junior scientists to develop and implement research in the cancer field. This opportunity allows for junior investigators to develop a research project, investigate a problem or question in the field of cancer, and further their intellectual development as a cancer researcher of the future. Under this award mechanism, the junior investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development. It should be clear that the proposed research is intellectually designed by the PI with assistance from the Mentor. Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated. Clinical trials will not be supported by this mechanism.
• Pre-Application Deadline: August 21, 2019
• Application Submission Deadline: September 11, 2019
Areas of Interest
To be considered for funding, applications for the FY19 PRCRP Horizon Award must address at least one of the FY19 PRCRP Topic Areas as directed by Congress. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), kidney, melanoma, or ovarian cancer will not be accepted. The FY19 PRCRP Topic Areas are listed below. • Bladder cancer • Blood cancers • Brain cancer • Cancer in children, adolescents, and young adults1 • Colorectal cancer • Immunotherapy2 • Listeria vaccine for cancer • Liver cancer • Lymphoma • Mesothelioma • Neuroblastoma • Pancreatic cancer • Pediatric brain tumors • Rare cancers3 • Stomach cancer
New for FY19: Studies involving melanoma (including rare subtypes of melanoma) should apply to the new FY19 Melanoma Research Program. Studies involving other skin cancers will be accepted by the PRCRP under an appropriate FY19 PRCRP Topic Area (i.e., immunotherapy).
In addition to addressing at least one of the required FY19 PRCRP Topic Areas, applications for the PRCRP Horizon Award must also address at least one of the FY19 PRCRP Military Health Focus Areas. Relevance to military health in medical research focuses on critical issues or gaps in biomedical knowledge that may affect the health and well-being of the military and their beneficiaries.
It is central to the vision and mission of the PRCRP that applications address how the proposed research is related to military health, mission readiness, and the cancer health needs of both deployed and non-deployed military personnel, their dependents, Veterans, and other military beneficiaries (i.e., family members of retirees). The FY19 PRCRP requires all applications answer at least one of the Military Health Focus Areas listed below:
• Environmental/exposure risk factors associated with cancer
• Gaps in cancer prevention, early detection/diagnosis, prognosis, treatment, and/or survivorship that may impact mission readiness and the health and well-being of military members, Veterans, their beneficiaries, and the general public
The PI must be either:
○ A predoctoral candidate within 2 years (excluding time in residency, clinical training, or on family medical leave) of completing required coursework, all laboratory rotations, successfully passing qualifying examinations, and is working in his/her Mentor’s laboratory by the time of the application submission deadline or
○ A postdoctoral fellow within 3 years (excluding time in medical residency, clinical training, or family medical leave) of completion of his/her terminal degree, and working in the Mentor’s laboratory at the time of the application submission deadline.
○ Each investigator may be named on only one FY19 PRCRP Horizon Award application as the PI
○ Must hold a position at or above the level of an Assistant Professor (or equivalent).
○ Must have a proven publication and active funding record in cancer research.
The anticipated direct costs budgeted for the entire period of performance for an FY19 PRCRP Horizon Award will not exceed $150,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.